The endocrine disruption screening market is projected to reach US$ 153.30 million by 2028 from US$ 126.53 million in 2021; it is expected to grow at a CAGR of 2.8% during 2021-2028. The report highlights trends prevailing in the market and factors driving its growth. The market growth is attributed to factors such as the increasing prevalence of endocrine disorders and the rising incidence of diabetes. However, the high cost of screening technology hampers the market growth.
The rising burden of cancer patients and especially hormone-related cancers patients will flourish the demand for endocrine disruption screening across the world. According to the National Institute of Cancer, as of January 2019, there were an estimated 16.9 million cancer survivors in the US. The number of cancer survivors is projected to increase to 22.2 million by 2030. According to cancer.gov, cancers that are diagnosed with the greatest frequency in the US are breast cancer, thyroid cancer, prostate cancer, colon and rectal cancer, endometrial cancer, kidney cancer, leukemia, liver lung cancer, melanoma, non-Hodgkin lymphoma, pancreatic cancer, and bladder cancer. Breast cancer is the most common cancer recorded in the US in 2021, with 284,200 new cases. Prostate cancer and lung cancer are the next most frequent cancers in the US. Most players concentrate on developing markets, such as India and China, owing to the large populations suffering from chronic diseases in these countries. With rising production costs against their solutions, healthcare companies are striving to produce sufficient revenue to meet their investors’ expectations. Advancements in biotechnology have increased the demand for diagnostics in the healthcare market, encouraging the introduction of more analytical systems and facilitating the shift toward personalized medicine. New opportunities mainly lie in infectious disease testing, molecular oncology, and pharmacogenomics arms in emerging countries.
The global endocrine disruption screening market, based on assay type, is bifurcated into in-vitro and in-vivo. The in-vitro segment held a larger share of the market in 2021 and is anticipated to register a higher CAGR in the market during the forecast period. By application, the market is bifurcated into natural materials and synthetic materials. In 2021, the natural materials segment held a larger share of the market. Moreover, the market for the same segment is expected to grow at a faster CAGR of 3.1% during 2021-2028. Based on sources of waste, the market is segmented into incineration and landfill, agricultural runoff, industrial and municipal effluents, pulp mill effluents, consumer products, and others. In 2021, the incineration and landfill segment held the largest share of the market. Moreover, the market for the same segment is expected to grow at the fastest CAGR of 3.5% from 2021 to 2028. The global endocrine disruption screening market, based on method, is segmented into estrogen receptor (ER) transactivation, androgen receptor (AR) transactivation, androgen receptor (AR) modulation, estrogen receptor-alpha (ER) binding, estrogen receptor beta (ER) binding, androgen receptor (AR) binding, steroidogenesis, aromatase assay, and others. In 2021, the estrogen receptor (ER) transactivation segment held the largest share of the market. Moreover, the market for the same segment is expected to grow at the fastest CAGR of 3.7% from 2021 to 2028. By end user, the market is segmented into pharmaceutical and biopharmaceutical companies, cosmetics and household product companies, food industry, and chemical industry. In 2021, the pharmaceutical and biopharmaceutical companies segment held the largest share of the market. Moreover, the market for the same segment is expected to grow at the fastest CAGR of 3.3% from 2021 to 2028.
A few of the major primary and secondary sources referred to while preparing the report on the endocrine disruption screening market are the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), the National Center for Biotechnology Information (NCBI), and National Institute of Cancer.Reasons to Buy
The rising burden of cancer patients and especially hormone-related cancers patients will flourish the demand for endocrine disruption screening across the world. According to the National Institute of Cancer, as of January 2019, there were an estimated 16.9 million cancer survivors in the US. The number of cancer survivors is projected to increase to 22.2 million by 2030. According to cancer.gov, cancers that are diagnosed with the greatest frequency in the US are breast cancer, thyroid cancer, prostate cancer, colon and rectal cancer, endometrial cancer, kidney cancer, leukemia, liver lung cancer, melanoma, non-Hodgkin lymphoma, pancreatic cancer, and bladder cancer. Breast cancer is the most common cancer recorded in the US in 2021, with 284,200 new cases. Prostate cancer and lung cancer are the next most frequent cancers in the US. Most players concentrate on developing markets, such as India and China, owing to the large populations suffering from chronic diseases in these countries. With rising production costs against their solutions, healthcare companies are striving to produce sufficient revenue to meet their investors’ expectations. Advancements in biotechnology have increased the demand for diagnostics in the healthcare market, encouraging the introduction of more analytical systems and facilitating the shift toward personalized medicine. New opportunities mainly lie in infectious disease testing, molecular oncology, and pharmacogenomics arms in emerging countries.
The global endocrine disruption screening market, based on assay type, is bifurcated into in-vitro and in-vivo. The in-vitro segment held a larger share of the market in 2021 and is anticipated to register a higher CAGR in the market during the forecast period. By application, the market is bifurcated into natural materials and synthetic materials. In 2021, the natural materials segment held a larger share of the market. Moreover, the market for the same segment is expected to grow at a faster CAGR of 3.1% during 2021-2028. Based on sources of waste, the market is segmented into incineration and landfill, agricultural runoff, industrial and municipal effluents, pulp mill effluents, consumer products, and others. In 2021, the incineration and landfill segment held the largest share of the market. Moreover, the market for the same segment is expected to grow at the fastest CAGR of 3.5% from 2021 to 2028. The global endocrine disruption screening market, based on method, is segmented into estrogen receptor (ER) transactivation, androgen receptor (AR) transactivation, androgen receptor (AR) modulation, estrogen receptor-alpha (ER) binding, estrogen receptor beta (ER) binding, androgen receptor (AR) binding, steroidogenesis, aromatase assay, and others. In 2021, the estrogen receptor (ER) transactivation segment held the largest share of the market. Moreover, the market for the same segment is expected to grow at the fastest CAGR of 3.7% from 2021 to 2028. By end user, the market is segmented into pharmaceutical and biopharmaceutical companies, cosmetics and household product companies, food industry, and chemical industry. In 2021, the pharmaceutical and biopharmaceutical companies segment held the largest share of the market. Moreover, the market for the same segment is expected to grow at the fastest CAGR of 3.3% from 2021 to 2028.
A few of the major primary and secondary sources referred to while preparing the report on the endocrine disruption screening market are the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), the National Center for Biotechnology Information (NCBI), and National Institute of Cancer.Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Endocrine Disruption Screening Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Endocrine Disruption Screening Market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 The Publisher's Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Endocrine Disruption Screening Market - By Assay Type
1.3.2 Global Endocrine Disruption Screening Market - By Application
1.3.3 Global Endocrine Disruption Screening Market - By Sources of waste
1.3.4 Global Endocrine Disruption Screening Market - By Method
1.3.5 Global Endocrine Disruption Screening Market - By End User
1.3.6 Global Endocrine Disruption Screening Market - By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Endocrine Disruption Screening Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East And Africa PEST Analysis
4.2.5 South And Central America PEST Analysis
4.3 Experts Opinion
5. Endocrine Disruption Screening Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Prevalence of Endocrine Disorders
5.1.2 Increasing Prevalence of Diabetes
5.2 Market Restraints
5.2.1 High Cost of Screening Technology
5.3 Market Opportunities
5.3.1 Scope for Expansion in Emerging Countries
5.4 Future Trends
5.5 Regulatory Approaches for Endocrine Disrupting
5.6 Impact Analysis
6. Endocrine Disruption Screening Market- Global Analysis
6.1 Global Endocrine Disruption Screening Market Revenue Forecast and Analysis
6.2 Global Endocrine Disruption Screening Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Global Endocrine Disruption Screening Market Revenue and Forecasts To 2028- by Assay Type
7.1 Overview
7.2 Global Endocrine Disruption Screening Market, By Assay Type, 2021 & 2028 (%)
7.3 In-Virto
7.3.1 Overview
7.3.2 In-Virto: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
7.4 In-Vivo
7.4.1 Overview
7.4.2 In-Vivo: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
8. Endocrine Disruption Screening Market Revenue and Forecasts To 2028 - Application
8.1 Overview
8.2 Global Endocrine Disruption Screening Market Share by Application - 2021 & 2028 (%)
8.3 Natural Materials
8.3.1 Overview
8.3.2 Natural Materials: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
8.4 Synthetic Materials
8.4.1 Overview
8.4.2 Synthetic Materials: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
9. Endocrine Disruption Screening Market Revenue and Forecasts To 2028 - Sources of Waste
9.1 Overview
9.2 Global Endocrine Disruption Screening Market Share by Sources of Waste - 2021 & 2028 (%)
9.3 Incineration and landfill
9.3.1 Overview
9.3.2 Incineration and landfill: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
9.4 Agricultural runoff
9.4.1 Overview
9.4.2 Agricultural runoff: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
9.5 Industrial and Municipal Effluents
9.5.1 Overview
9.5.2 Industrial and Municipal Effluents: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
9.6 Pulp Mill Effluents
9.6.1 Overview
9.6.2 Pulp Mill Effluents: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
9.7 Consumer Products
9.7.1 Overview
9.7.2 Consumer Products: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
9.8 Others
9.8.1 Overview
9.8.2 Others: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
10. Endocrine Disruption Screening Market Revenue and Forecasts To 2028 - Method
10.1 Overview
10.2 Global Endocrine Disruption Screening Market Share by Method - 2021 & 2028 (%)
10.3 Estrogen Receptor (ER) Transactivation
10.3.1 Overview
10.3.2 Estrogen Receptor (ER) Transactivation: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
10.4 Androgen Receptor (AR) Transactivation
10.4.1 Overview
10.4.2 Androgen Receptor (AR) Transactivation: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
10.5 Androgen Receptor (AR) Modulation
10.5.1 Overview
10.5.2 Androgen Receptor (AR) Modulation: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
10.6 Estrogen Receptor-Alpha (ER-alpha) Binding
10.6.1 Overview
10.6.2 Estrogen Receptor-Alpha (ER-alpha) Binding: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
10.7 Estrogen Receptor beta (ER-beta) Binding
10.7.1 Overview
10.7.2 Estrogen Receptor beta (ER-beta) Binding: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
10.8 Androgen Receptor (AR) Binding
10.8.1 Overview
10.8.2 Androgen Receptor (AR) Binding: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
10.9 Steroidogenesis
10.9.1 Overview
10.9.2 Steroidogenesis: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
10.10 Aromatase Assay
10.10.1 Overview
10.10.2 Aromatase Assay: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
10.11 Others
10.11.1 Overview
10.11.2 Others: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
11. Endocrine Disruption Screening Market Revenue and Forecasts To 2028 - End Use
11.1 Overview
11.2 Global Endocrine Disruption Screening Market Share by End Use - 2021 & 2028 (%)
11.3 Pharmaceutical and Biopharmaceutical Companies
11.3.1 Overview
11.3.2 Pharmaceutical and Biopharmaceutical Companies: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
11.4 Cosmetics and Household Product Companies
11.4.1 Overview
11.4.2 Cosmetics and Household Product Companies: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
11.5 Food Industry
11.5.1 Overview
11.5.2 Food Industry: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
11.6 Chemical Industry
11.6.1 Overview
11.6.2 Chemical Industry: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
12. Endocrine Disruption Screening Market Revenue and Forecasts to 2028 - Geographical Analysis
12.1 North America: Endocrine Disruption Screening Market
12.1.1 Overview
12.1.2 North America: Endocrine Disruption Screening Market - Revenue and Forecast to 2028 (US$ Thousands)
12.1.3 North America: Endocrine Disruption Screening Market, by Assay Type , 2019-2028 (US$ Thousands)
12.1.4 North America: Endocrine Disruption Screening Market, by Application , 2019-2028 (US$ Thousands)
12.1.5 North America: Endocrine Disruption Screening Market, by Sources of waste , 2019-2028 (US$ Thousands)
12.1.6 North America: Endocrine Disruption Screening Market, by Method , 2019-2028 (US$ Thousands)
12.1.7 North America: Endocrine Disruption Screening Market, by End-user , 2019-2028 (US$ Thousands)
12.1.8 North America: Endocrine Disruption Screening Market, by Country, 2021 & 2028 (%)
12.1.8.1 US: Endocrine Disruption Screening Market - Revenue and Forecast to 2028 (US$ Thousands)
12.1.8.1.1 Overview
12.1.8.1.2 US: Endocrine Disruption Screening Market - Revenue and Forecast to 2028 (US$ Thousands)
12.1.8.1.3 US: Endocrine Disruption Screening Market, by Assay Type , 2019-2028 (US$ Thousands)
12.1.8.1.4 US: Endocrine Disruption Screening Market, by Application , 2019-2028 (US$ Thousands)
12.1.8.1.5 US: Endocrine Disruption Screening Market, by Sources of waste , 2019-2028 (US$ Thousands)
12.1.8.1.6 US: Endocrine Disruption Screening Market, by Method , 2019-2028 (US$ Thousands)
12.1.8.1.7 US: Endocrine Disruption Screening Market, by End-user , 2019-2028 (US$ Thousands)
12.1.8.2 Canada: Endocrine Disruption Screening Market - Revenue and Forecast to 2028 (US$ Thousands)
12.1.8.2.1 Overview
12.1.8.2.2 Canada: Endocrine Disruption Screening Market - Revenue and Forecast to 2028 (US$ Thousands)
12.1.8.2.3 Canada: Endocrine Disruption Screening Market, by Assay Type , 2019-2028 (US$ Thousands)
12.1.8.2.4 Canada: Endocrine Disruption Screening Market, by Application , 2019-2028 (US$ Thousands)
12.1.8.2.5 Canada: Endocrine Disruption Screening Market, by Sources of waste , 2019-2028 (US$ Thousands)
12.1.8.2.6 Canada: Endocrine Disruption Screening Market, by Method , 2019-2028 (US$ Thousands)
12.1.8.2.7 Canada: Endocrine Disruption Screening Market, by End-user , 2019-2028 (US$ Thousands)
12.1.8.3 Mexico: Endocrine Disruption Screening Market - Revenue and Forecast to 2028 (US$ Thousands)
12.1.8.3.1 Overview
12.1.8.3.2 Mexico: Endocrine Disruption Screening Market - Revenue and Forecast to 2028 (US$ Thousands)
12.1.8.3.3 Mexico: Endocrine Disruption Screening Market, by Assay Type , 2019-2028 (US$ Thousands)
12.1.8.3.4 Mexico: Endocrine Disruption Screening Market, by Application , 2019-2028 (US$ Thousands)
12.1.8.3.5 Mexico: Endocrine Disruption Screening Market, by Sources of waste , 2019-2028 (US$ Thousands)
12.1.8.3.6 Mexico: Endocrine Disruption Screening Market, by Method , 2019-2028 (US$ Thousands)
12.1.8.3.7 Mexico: Endocrine Disruption Screening Market, by End-user , 2019-2028 (US$ Thousands)
12.2 Europe: Endocrine Disruption Screening Market
12.2.1 Overview
12.2.2 Europe: Endocrine Disruption Screening Market - Revenue and Forecast to 2028 (US$ Thousand)
12.2.3 Europe: Endocrine Disruption Screening Market, by Assay Type - Revenue and Forecast to 2028 (US$ Thousand)
12.2.4 Europe: Endocrine Disruption Screening Market, by Application, 2019-2028 (US$ Thousand)
12.2.5 Europe: Endocrine Disruption Screening Market, by Sources of waste - Revenue and Forecast to 2028 (US$ Thousand)
12.2.6 Europe: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
12.2.7 Europe: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8 Europe: Endocrine Disruption Screening Market, by Country, 2021 & 2028 (%)
12.2.8.1 Germany: Endocrine Disruption Screening Market - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.1.1 Overview
12.2.8.1.2 Germany: Endocrine Disruption Screening Market - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.1.3 Germany: Endocrine Disruption Screening Market, by Assay Type - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.1.4 Germany: Endocrine Disruption Screening Market, by Application, 2019-2028 (US$ Thousand)
12.2.8.1.5 Germany: Endocrine Disruption Screening Market, by Sources of waste - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.1.6 Germany: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.1.7 Germany: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.2 France: Endocrine Disruption Screening Market - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.2.1 Overview
12.2.8.2.2 France: Endocrine Disruption Screening Market - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.2.3 France: Endocrine Disruption Screening Market, by Assay Type - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.2.4 France: Endocrine Disruption Screening Market, by Application, 2019-2028 (US$ Thousand)
12.2.8.2.5 France: Endocrine Disruption Screening Market, by Sources of waste - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.2.6 France: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.2.7 France: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.3 UK: Endocrine Disruption Screening Market - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.3.1 Overview
12.2.8.3.2 UK: Endocrine Disruption Screening Market - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.3.3 UK: Endocrine Disruption Screening Market, by Assay Type - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.3.4 UK: Endocrine Disruption Screening Market, by Application, 2019-2028 (US$ Thousand)
12.2.8.3.5 UK: Endocrine Disruption Screening Market, by Sources of waste - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.3.6 UK: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.3.7 UK: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.4 Italy: Endocrine Disruption Screening Market - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.4.1 Overview
12.2.8.4.2 Italy: Endocrine Disruption Screening Market - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.4.3 Italy: Endocrine Disruption Screening Market, by Assay Type - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.4.4 Italy: Endocrine Disruption Screening Market, by Application, 2019-2028 (US$ Thousand)
12.2.8.4.5 Italy: Endocrine Disruption Screening Market, by Sources of waste - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.4.6 Italy: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.4.7 Italy: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.5 Spain: Endocrine Disruption Screening Market - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.5.1 Overview
12.2.8.5.2 Spain: Endocrine Disruption Screening Market - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.5.3 Spain: Endocrine Disruption Screening Market, by Assay Type - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.5.4 Spain: Endocrine Disruption Screening Market, by Application, 2019-2028 (US$ Thousand)
12.2.8.5.5 Spain: Endocrine Disruption Screening Market, by Sources of waste - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.5.6 Spain: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.5.7 Spain: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.6 Rest of Europe: Endocrine Disruption Screening Market - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.6.1 Overview
12.2.8.6.2 Rest of Europe: Endocrine Disruption Screening Market - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.6.3 Rest of Europe: Endocrine Disruption Screening Market, by Assay Type - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.6.4 Rest of Europe: Endocrine Disruption Screening Market, by Application, 2019-2028 (US$ Thousand)
12.2.8.6.5 Rest of Europe: Endocrine Disruption Screening Market, by Sources of waste - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.6.6 Rest of Europe: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.6.7 Rest of Europe: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
12.3 Asia Pacific Endocrine Disruption Screening Market Revenue and Forecasts To 2028
12.3.1 Overview
12.3.2 Asia Pacific Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.3.3 Asia Pacific: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
12.3.4 Asia Pacific: Endocrine Disruption Screening Market, by Application, 2019-2028 (US$ Thousand)
12.3.5 Asia Pacific: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
12.3.6 Asia Pacific: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
12.3.7 Asia Pacific: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
12.3.8 Asia Pacific: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Country (%)
12.3.8.1 Japan: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.3.8.1.1 Overview
12.3.8.1.2 Japan: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.3.8.1.3 Japan: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
12.3.8.1.4 Japan: Endocrine Disruption Screening Market, by Application, 2019-2028 (US$ Thousand)
12.3.8.1.5 Japan: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
12.3.8.1.6 Japan: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
12.3.8.1.7 Japan: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
12.3.8.2 China: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.3.8.2.1 Overview
12.3.8.2.2 China: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.3.8.2.3 China: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type US$ Thousand)
12.3.8.2.4 China: Endocrine Disruption Screening Market, by Application, 2019-2028 (US$ Thousand)
12.3.8.2.5 China: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
12.3.8.2.6 China: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
12.3.8.2.7 China: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
12.3.8.3 India Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.3.8.3.1 Overview
12.3.8.3.2 India: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.3.8.3.3 India: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
12.3.8.3.4 India: Endocrine Disruption Screening Market, by Application, 2019-2028 (US$ Thousand)
12.3.8.3.5 India: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
12.3.8.3.6 India: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
12.3.8.3.7 India: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
12.3.8.4 South Korea: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.3.8.4.1 Overview
12.3.8.4.2 South Korea: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.3.8.4.3 South Korea: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
12.3.8.4.4 South Korea: Endocrine Disruption Screening Market, by Application, 2019-2028 (US$ Thousand)
12.3.8.4.5 South Korea: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
12.3.8.4.6 South Korea: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
12.3.8.4.7 South Korea: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
12.3.8.5 Australia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.3.8.5.1 Overview
12.3.8.5.2 Australia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.3.8.5.3 Australia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
12.3.8.5.4 Australia: Endocrine Disruption Screening Market, by Application, 2019-2028 (US$ Thousand)
12.3.8.5.5 Australia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
12.3.8.5.6 Australia: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
12.3.8.5.7 Australia: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
12.3.8.6 Rest of Asia Pacific: Endocrine Disruption Screening Market - Revenue and Forecast to 2028 (US$ Thousand)
12.3.8.6.1 Overview
12.3.8.6.2 Rest of Asia Pacific: Endocrine Disruption Screening Market - Revenue and Forecast to 2028 (US$ Thousand)
12.3.8.6.3 Rest of Asia Pacific: Endocrine Disruption Screening Market, by Assay Type, 2019-2028 (US$ Thousand)
12.3.8.6.4 Rest of Asia Pacific: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Application (US$ Thousand)
12.3.8.6.5 Rest of Asia Pacific: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
12.3.8.6.6 Rest of Asia Pacific: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
12.3.8.6.7 Rest of Asia Pacific: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
12.4 Middle East & Africa Endocrine Disruption Screening Market Revenue and Forecasts To 2028
12.4.1 Overview
12.4.2 Middle East & Africa Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.4.3 Middle East & Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
12.4.4 Middle East & Africa: Endocrine Disruption Screening Market, by Sub- Application, 2019-2028 (US$ Thousand)
12.4.5 Middle East & Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
12.4.6 Middle East & Africa: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
12.4.7 Middle East & Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By End User (US$ Thousand)
12.4.8 Middle East & Africa Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Country (%)
12.4.8.1 UAE: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.4.8.1.1 Overview
12.4.8.1.2 UAE: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.4.8.1.3 UAE: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
12.4.8.1.4 UAE: Endocrine Disruption Screening Market, by Sub- Application, 2019-2028 (US$ Thousand)
12.4.8.1.5 UAE: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
12.4.8.1.6 UAE: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
12.4.8.1.7 UAE: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By End User (US$ Thousand)
12.4.8.2 Saudi Arabia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.4.8.2.1 Overview
12.4.8.2.2 Saudi Arabia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.4.8.2.3 Saudi Arabia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
12.4.8.2.4 UAE: Endocrine Disruption Screening Market, by Sub- Application, 2019-2028 (US$ Thousand)
12.4.8.2.5 Saudi Arabia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
12.4.8.2.6 Saudi Arabia: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
12.4.8.2.7 Saudi Arabia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By End User (US$ Thousand)
12.4.8.3 South Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.4.8.3.1 Overview
12.4.8.3.2 South Africa Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.4.8.3.3 South Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
12.4.8.3.4 South Africa: Endocrine Disruption Screening Market, by Sub- Application, 2019-2028 (US$ Thousand)
12.4.8.3.5 South Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
12.4.8.3.6 South Africa: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
12.4.8.3.7 South Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By End User (US$ Thousand)
12.4.8.4 Rest of Middle East and Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.4.8.4.1 Overview
12.4.8.4.2 Rest of Middle East and Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.4.8.4.3 Rest of Middle East and Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
12.4.8.4.4 Rest of Middle East and Africa: Endocrine Disruption Screening Market, by Sub- Application, 2019-2028 (US$ Thousand)
12.4.8.4.5 Rest of Middle East and Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
12.4.8.4.6 Rest of Middle East and Africa: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
12.4.8.4.7 Rest of Middle East and Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By End User (US$ Thousand)
12.5 South And Central America Endocrine Disruption Screening Market Revenue and Forecasts To 2028
12.5.1 Overview
12.5.2 South and Central America Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.5.3 South and Central America Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
12.5.4 South and Central America: Endocrine Disruption Screening Market, by Application, 2019-2028 (US$ Thousand)
12.5.5 South and Central America: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
12.5.6 South and Central America: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
12.5.7 South and Central America: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
12.5.8 South and Central America Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Country (%)
12.5.8.1 Argentina Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.5.8.1.1 Overview
12.5.8.1.2 Argentina Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.5.8.1.3 Argentina: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
12.5.8.1.4 Argentina: Endocrine Disruption Screening Market, by Application, 2019-2028 (US$ Thousand)
12.5.8.1.5 Argentina: Endocrine Disruption Screening Market Revenue and Forecasts To 2028, By Sources of waste (US$ Thousand)
12.5.8.1.6 Argentina: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
12.5.8.1.7 Argentina: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
12.5.8.2 Brazil: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.5.8.2.1 Overview
12.5.8.2.2 Brazil: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.5.8.2.3 Brazil: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
12.5.8.2.4 Brazil: Endocrine Disruption Screening Market, by Application, 2019-2028 (US$ Thousand)
12.5.8.2.5 Brazil: Endocrine Disruption Screening Market Revenue and Forecasts To 2028, By Sources of waste (US$ Thousand)
12.5.8.2.6 Brazil: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
12.5.8.2.7 Brazil: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
12.5.8.3 Rest of South and Central America: Endocrine Disruption Screening Market- Revenue and Forecast to 2028 (USD Mn)
12.5.8.3.1 Overview
12.5.8.3.2 Rest of South and Central America: Endocrine Disruption Screening Market- Revenue and Forecast to 2028 (USD Mn)
12.5.8.3.3 Rest of South & Central America: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
12.5.8.3.4 Rest of South & Central America: Endocrine Disruption Screening Market, by Application, 2019-2028 (US$ Thousand)
12.5.8.3.5 Rest of South & Central America: Endocrine Disruption Screening Market Revenue and Forecasts To 2028, By Sources of waste (US$ Thousand)
12.5.8.3.6 Rest of South and Central America: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
12.5.8.3.7 Rest of South and Central America: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
13. Impact Of COVID-19 Pandemic on Endocrine Disruption Screening Market
13.1 North America: Impact Assessment of COVID-19 Pandemic
13.2 Europe: Impact Assessment of COVID-19 Pandemic
13.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
13.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
13.5 South and Central America: Impact Assessment of COVID-19 Pandemic
14. Endocrine Disruption Screening Market-Industry Landscape
14.1 Overview
14.2 Growth Strategies Done by the Companies in the Market (%)
14.3 Organic Developments
14.3.1 Overview
14.4 Inorganic Developments
14.4.1 Overview
15. Company Profiles
15.1 CREATIVE BIOARRAY
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 CHARLES RIVER LABORATORIES, INC.
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Eurofins Scientific Ltd.
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 SGS SA
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 XENOMETRIX AG
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 SMITHERS
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 JRF Global
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 Mérieux NutriSciences
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 aALPHA ANALYTICAL, Inc.
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
16. Appendix
16.1 About The Publisher
16.2 Glossary of Terms
List of Tables
Table 1. North America Endocrine Disruption Screening Market, by Assay Type - Revenue and Forecast to 2028 (US$ Thousands)
Table 2. North America Endocrine Disruption Screening Market, by Application - Revenue and Forecast to 2028 (USD Thousands)
Table 3. North America Endocrine Disruption Screening Market, by Sources of waste - Revenue and Forecast to 2028 (US$ Thousands)
Table 4. North America Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousands)
Table 5. North America Endocrine Disruption Screening Market, by End-user - Revenue and Forecast to 2028 (US$ Thousands)
Table 6. US Endocrine Disruption Screening Market, by Assay Type - Revenue and Forecast to 2028 (US$ Thousands)
Table 7. US Endocrine Disruption Screening Market, by Application - Revenue and Forecast to 2028 (US$ Thousands)
Table 8. US Endocrine Disruption Screening Market, by Sources of waste - Revenue and Forecast to 2028 (US$ Thousands)
Table 9. US Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousands)
Table 10. US Endocrine Disruption Screening Market, by End-user - Revenue and Forecast to 2028 (US$ Thousands)
Table 11. Canada: Endocrine Disruption Screening Market, by Assay Type - Revenue and Forecast to 2028 (US$ Thousands)
Table 12. Canada Endocrine Disruption Screening Market, by Application - Revenue and Forecast to 2028 (US$ Thousands)
Table 13. Canada Endocrine Disruption Screening Market, by Sources of waste - Revenue and Forecast to 2028 (US$ Thousands)
Table 14. Canada Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousands)
Table 15. Canada Endocrine Disruption Screening Market, by End-user - Revenue and Forecast to 2028 (US$ Thousands)
Table 16. Mexico: Endocrine Disruption Screening Market, by Assay Type - Revenue and Forecast to 2028 (US$ Thousands)
Table 17. Mexico Endocrine Disruption Screening Market, by Application - Revenue and Forecast to 2028 (US$ Thousands)
Table 18. Mexico Endocrine Disruption Screening Market, by Sources of waste - Revenue and Forecast to 2028 (US$ Thousands)
Table 19. Mexico Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousands)
Table 20. Mexico Endocrine Disruption Screening Market, by End-user - Revenue and Forecast to 2028 (US$ Thousands)
Table 21. Europe: Endocrine Disruption Screening Market, by Assay Type - Revenue and Forecast to 2028 (US$ Thousand)
Table 22. Europe: Endocrine Disruption Screening Market, by Application - Revenue and Forecast to 2028 (US$ Thousand)
Table 23. Europe: Endocrine Disruption Screening Market, by Sources of waste - Revenue and Forecast to 2028 (US$ Thousand)
Table 24. Europe: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
Table 25. Europe: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 26. Germany: Endocrine Disruption Screening Market, by Assay Type - Revenue and Forecast to 2028 (US$ Thousand)
Table 27. Germany: Endocrine Disruption Screening Market, by Application - Revenue and Forecast to 2028 (US$ Thousand)
Table 28. Germany: Endocrine Disruption Screening Market, by Sources of waste - Revenue and Forecast to 2028 (US$ Thousand)
Table 29. Germany: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
Table 30. Germany: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 31. France Endocrine Disruption Screening Market, by Assay Type - Revenue and Forecast to 2028 (USD Thousand)
Table 32. France: Endocrine Disruption Screening Market, by Application - Revenue and Forecast to 2028 (US$ Thousand)
Table 33. France: Endocrine Disruption Screening Market, by Sources of waste - Revenue and Forecast to 2028 (US$ Thousand)
Table 34. France: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
Table 35. France: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 36. UK: Endocrine Disruption Screening Market, by Assay Type - Revenue and Forecast to 2028 (US$ Thousand)
Table 37. UK: Endocrine Disruption Screening Market, by Application - Revenue and Forecast to 2028 (US$ Thousand)
Table 38. UK: Endocrine Disruption Screening Market, by Sources of waste - Revenue and Forecast to 2028 (US$ Thousand)
Table 39. UK: Endocrine Disruption Screening Market, by Method- Revenue and Forecast to 2028 (US$ Thousand)
Table 40. UK: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 41. Italy: Endocrine Disruption Screening Market, by Assay Type - Revenue and Forecast to 2028 (US$ Thousand)
Table 42. Italy: Endocrine Disruption Screening Market, by Application - Revenue and Forecast to 2028 (US$ Thousand)
Table 43. Italy: Endocrine Disruption Screening Market, by Sources of waste - Revenue and Forecast to 2028 (US$ Thousand)
Table 44. Italy: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
Table 45. Italy: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 46. Spain: Endocrine Disruption Screening Market, by Assay Type - Revenue and Forecast to 2028 (US$ Thousand)
Table 47. Spain: Endocrine Disruption Screening Market, by Application - Revenue and Forecast to 2028 (US$ Thousand)
Table 48. Spain: Endocrine Disruption Screening Market, by Sources of waste - Revenue and Forecast to 2028 (US$ Thousand)
Table 49. Spain: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
Table 50. Spain: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 51. Rest of Europe: Endocrine Disruption Screening Market, by Assay Type - Revenue and Forecast to 2028 (US$ Thousand)
Table 52. Rest of Europe: Endocrine Disruption Screening Market, by Application - Revenue and Forecast to 2028 (US$ Thousand)
Table 53. Rest of Europe: Endocrine Disruption Screening Market, by Sources of waste - Revenue and Forecast to 2028 (US$ Thousand)
Table 54. Rest of Europe: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
Table 55. Rest of Europe: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 56. Asia Pacific: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand).
Table 57. Asia Pacific: Endocrine Disruption Screening Market, by Application - Revenue and Forecast to 2028 (US$ Thousand)
Table 58. Asia Pacific: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
Table 59. Asia Pacific: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
Table 60. Asia Pacific: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 61. Japan: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
Table 62. Japan: Endocrine Disruption Screening Market, by Application - Revenue and Forecast to 2028 (US$ Thousand)
Table 63. Japan: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
Table 64. Japan: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
Table 65. Japan: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 66. China: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
Table 67. China: Endocrine Disruption Screening Market, by Application - Revenue and Forecast to 2028 (US$ Thousand)
Table 68. China: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
Table 69. China: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
Table 70. China: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 71. India: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
Table 72. India: Endocrine Disruption Screening Market, by Application - Revenue and Forecast to 2028 (US$ Thousand)
Table 73. India: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
Table 74. India: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
Table 75. India: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 76. South Korea: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
Table 77. South Korea: Endocrine Disruption Screening Market, by Application - Revenue and Forecast to 2028 (US$ Thousand)
Table 78. South Korea: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
Table 79. South Korea: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
Table 80. South Korea: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 81. Australia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
Table 82. Australia: Endocrine Disruption Screening Market, by Application- Revenue and Forecast to 2028 (US$ Thousand)
Table 83. Australia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
Table 84. Australia: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
Table 85. Australia: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 86. Rest of Asia Pacific: Endocrine Disruption Screening Market, by Assay Type - Revenue and Forecast to 2028 (US$ Thousand)
Table 87. Rest of Asia Pacific: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Application (US$ Thousand)
Table 88. Rest of Asia Pacific: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
Table 89. Rest of Asia Pacific: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
Table 90. Rest of Asia Pacific: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 91. Middle East & Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
Table 92. Middle East & Africa: Endocrine Disruption Screening Market, by Sub- Application - Revenue and Forecast to 2028 (US$ Thousand)
Table 93. Middle East & Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
Table 94. Middle East & Africa: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
Table 95. Middle East & Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By End User (US$ Thousand)
Table 96. UAE: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
Table 97. UAE: Endocrine Disruption Screening Market, by Sub- Application - Revenue and Forecast to 2028 (US$ Thousand)
Table 98. UAE: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
Table 99. UAE: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
Table 100. UAE: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By End User (US$ Thousand)
Table 101. Saudi Arabia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
Table 102. UAE: Endocrine Disruption Screening Market, by Sub- Application - Revenue and Forecast to 2028 (US$ Thousand)
Table 103. Saudi Arabia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
Table 104. Saudi Arabia: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
Table 105. Saudi Arabia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By End User (US$ Thousand)
Table 106. South Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
Table 107. South Africa: Endocrine Disruption Screening Market, by Sub- Application - Revenue and Forecast to 2028 (US$ Thousand)
Table 108. South Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
Table 109. South Africa: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
Table 110. South Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By End User (US$ Thousand)
Table 111. Rest of Middle East and Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
Table 112. Rest of Middle East and Africa: Endocrine Disruption Screening Market, by Sub- Application - Revenue and Forecast to 2028 (US$ Thousand)
Table 113. Rest of Middle East and Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
Table 114. Rest of Middle East and Africa: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
Table 115. Rest of Middle East and Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By End User (US$ Thousand)
Table 116. South and Central America Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
Table 117. South and Central America: Endocrine Disruption Screening Market, by Application - Revenue and Forecast to 2028 (US$ Thousand)
Table 118. South and Central America: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
Table 119. South and Central America: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
Table 120. South and Central America: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 121. Argentina: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
Table 122. Argentina: Endocrine Disruption Screening Market, by Application - Revenue and Forecast to 2028 (US$ Thousand)
Table 123. Argentina: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
Table 124. Argentina: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
Table 125. Argentina: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 126. Brazil: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
Table 127. Brazil: Endocrine Disruption Screening Market, by Application - Revenue and Forecast to 2028 (US$ Thousand)
Table 128. Brazil: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
Table 129. Brazil: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
Table 130. Brazil: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 131. Rest of South & Central America: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
Table 132. Rest of South & Central America: Endocrine Disruption Screening Market, by Application - Revenue and Forecast to 2028 (US$ Thousand)
Table 133. Rest of South & Central America: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
Table 134. Rest of South and Central America: Endocrine Disruption Screening Market, by Method - Revenue and Forecast to 2028 (US$ Thousand)
Table 135. Rest of South and Central America: Endocrine Disruption Screening Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 136. organic Developments Done By Companies
Table 137. Inorganic Developments Done By Companies
Table 138. Glossary of TermsList of Figures
Figure 1. Endocrine Disruption Screening Market Segmentation
Figure 2. Endocrine Disruption Screening Market, By Region
Figure 3. Global Endocrine Disruption Screening Market Overview
Figure 4. In-Vitro Segment Held Largest Share of Assay Type Segment in Endocrine Disruption Screening Market
Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Endocrine Disruption Screening Market, by Geography (US$ Thousand)
Figure 7. Global Endocrine Disruption Screening Market- Leading Country Markets (US$ Thousand)
Figure 8. Global Endocrine Disruption Screening Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East And Africa: PEST Analysis
Figure 13. South And Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Impact Analysis of Drivers and Restraints Pertaining to Endocrine Disruption Screening Market
Figure 16. Global Endocrine Disruption Screening Market- Revenue Forecast and Analysis - 2021 - 2028
Figure 17. Global Endocrine Disruption Screening Market - By Geography Forecast and Analysis - 2021 - 2028
Figure 18. Market Positioning of Key Players in Global Endocrine Disruption Screening Market
Figure 19. Global Endocrine Disruption Screening Market, by Assay Type, 2021 & 2028 (%)
Figure 20. In-Virto: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 21. In-Vivo: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 22. Global Endocrine Disruption Screening Market Share by Application - 2021 & 2028 (%)
Figure 23. Natural Materials: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 24. Synthetic Materials: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 25. Global Endocrine Disruption Screening Market Share by Sources of Waste - 2021 & 2028 (%)
Figure 26. Natural Materials: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 27. Agricultural runoff: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 28. Industrial and Municipal Effluents: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 29. Pulp Mill Effluents: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 30. Consumer Products: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 31. Others: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 32. Global Endocrine Disruption Screening Market Share by Method - 2021 & 2028 (%)
Figure 33. Estrogen Receptor (ER) Transactivation: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 34. Androgen Receptor (AR) Transactivation: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 35. Androgen Receptor (AR) Modulation: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 36. Estrogen Receptor-Alpha (ER-alpha) Binding: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 37. Estrogen Receptor beta (ER-beta) Binding: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 38. Androgen Receptor (AR) Binding: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 39. Steroidogenesis: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 40. Aromatase Assay: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 41. Others: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 42. Global Endocrine Disruption Screening Market Share by End Use - 2021 & 2028 (%)
Figure 43. Pharmaceutical and Biopharmaceutical Companies: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 44. Cosmetics and Household Product Companies: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 45. Food Industry: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 46. Chemical Industry: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 47. North America: Endocrine Disruption Screening Market, by Key Country - Revenue (2021) (US$ Thousands)
Figure 48. North America Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 49. North America: Endocrine Disruption Screening Market, by Country, 2021 & 2028 (%)
Figure 50. US: Endocrine Disruption Screening Market - Revenue and Forecast to 2028 (US$ Thousands)
Figure 51. Canada: Endocrine Disruption Screening Market - Revenue and Forecast to 2028 (US$ Thousands)
Figure 52. Mexico: Endocrine Disruption Screening Market - Revenue and Forecast to 2028 (US$ Thousands)
Figure 53. Europe: Endocrine Disruption Screening Market, by Key Country - Revenue (2021) (US$ Thousand)
Figure 54. Europe: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 55. Europe: Endocrine Disruption Screening Market, by Country, 2021 & 2028 (%)
Figure 56. Germany: Endocrine Disruption Screening Market - Revenue and Forecast to 2028 (US$ Thousand)
Figure 57. France: Endocrine Disruption Screening Market - Revenue and Forecast to 2028 (US$ Thousand)
Figure 58. UK: Endocrine Disruption Screening Market - Revenue and Forecast to 2028 (US$ Thousand)
Figure 59. Italy: Endocrine Disruption Screening Market - Revenue and Forecast to 2028 (US$ Thousand)
Figure 60. Spain: Endocrine Disruption Screening Market - Revenue and Forecast to 2028 (US$ Thousand)
Figure 61. Rest of Europe: Endocrine Disruption Screening Market - Revenue and Forecast to 2028 (US$ Thousand)
Figure 62. Asia Pacific Endocrine Disruption Screening Market Overview, by Country (2021)
Figure 63. Asia Pacific: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 64. Asia Pacific: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Country (%)
Figure 65. Japan: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 66. China: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 67. India: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 68. South Korea: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 69. Australia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 70. Rest of Asia Pacific: Endocrine Disruption Screening Market - Revenue and Forecast to 2028 (US$ Thousand)
Figure 71. Middle East & Africa Endocrine Disruption Screening Market Revenue Overview, by Country, 2021 (US$ Thousand)
Figure 72. Middle East & Africa Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 73. Middle East & Africa Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Country (%)
Figure 74. UAE: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 75. Saudi Arabia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 76. South Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 77. Rest of Middle East and Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 78. South and Central America Endocrine Disruption Screening Market Revenue Overview, by Country, 2021 (US$ Thousand)
Figure 79. South and Central America Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 80. South and Central America Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Country (%)
Figure 81. Argentina Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 82. Brazil: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 83. Rest of South and Central America: Endocrine Disruption Screening Market- Revenue and Forecast to 2028 (USD Mn)
Figure 84. Impact of COVID-19 Pandemic in North American Country Markets
Figure 85. Impact of COVID-19 Pandemic in European Country Markets
Figure 86. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 87. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 88. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets
Figure 89. Growth Strategies Done by the Companies in the Market (%)
Companies Mentioned
- CREATIVE BIOARRAY
- XENOMETRIX AG
- CHARLES RIVER
- EUROFINS SCIENTIFIC
- SMITHERS
- SGS SA
- JRF GLOBAL
- MéRIEUX NUTRISCIENCES
- ALPHA ANALYTICAL
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 226 |
| Published | November 2021 |
| Forecast Period | 2021 - 2028 |
| Estimated Market Value ( USD | $ 126.53 Million |
| Forecasted Market Value ( USD | $ 153.3 Million |
| Compound Annual Growth Rate | 2.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 9 |
